Boston Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston Medical Center sits in the top decile of US sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count).
Boston Medical Center: 253 sponsored US clinical trials, 28 recruiting.
Boston Medical Center sponsors 253 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 177 completed. 18 of these trials are in Phase 3-4 (later-stage) and 47 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 5 trials.
Top-decile sponsor footprint
Boston Medical Center ranks in the top decile of sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
177 of 212 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
253 total, page 2 of 6
Improving Treatment and Retention Adherence in Nontraditional Settings
NCT04973254
Intrauterine Device (IUD) Self Removal
NCT05191238
Posterior cerebraL ArTery Occlusion Study
NCT05291637
Virtual Group Fitness and Nutrition Intervention for Individuals With Psychosis
NCT04783246
Methadone and Medication Abortion
NCT04941443
Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
NCT04596267
Implementing a Skills Training Evidence-Based Treatment for Posttraumatic Stress Disorder in Primary Care
NCT04937504
Hyperglycemia in Neurosurgery
NCT05236751
Group-based Mindfulness for Chronic Pain in the Primary Care Setting
NCT04129450
Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage
NCT04934020
Benzodiazepine Discontinuation in Opioid Agonist Therapy
NCT04109118
Reducing Food Insecurity During COVID-19
NCT04652596
Sickle Cell Anemia WE CARE
NCT03716726
Coaching for HCV and HIV
NCT04314414
Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus
NCT04460326
Etoposide in Patients With COVID-19 Infection
NCT04356690
Pilot Study of Motivational Interviewing for Loved Ones
NCT04010747
CT (Computerized Tomography) for Late EndovasculAr Reperfusion
NCT04096248
Diabetes eConsult Non-Inferiority Study
NCT04089202
Tax Preparation Pilot
NCT04135469
Kids FACE FEARS Comparative Effectiveness Research
NCT03707158
Small Moments Big Impact (SMBI)
NCT03887832
Fecal Microbiota Transplant for Primary CDI
NCT03795233
Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
NCT03591770
Calibration Study of a Blood Alcohol Level Smart Watch
NCT03574181
Family Partner Navigation for Children
NCT03569449
THRIVE+ Pharmacy Liaison-Patient Navigation Intervention
NCT03919084
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
NCT03645408
IText For ICOUGH: Improving Ambulation of Surgical Patients Through Text Messaging
NCT03834428
Response to Relapse in Office-Based Opioid Treatment Trial
NCT03812107
Pilot Simulation RCT of Telemedical Support for Paramedics
NCT03742167
MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study
NCT03718104
Platysma Incision Cosmesis
NCT03338608
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
NCT03346915
Hospital-based Patient Navigation and Smoking Cessation
NCT03452371
Superior Venous Access, Midline vs Ultrasound IVs
NCT03440944
Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers
NCT03271528
Improving Outcomes for Low-Income Mothers With Depression
NCT03221556
Secondary Prevention of Atrial Fibrilation
NCT03259893
Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
NCT02994784
ECA vs E-Document Explanation
NCT03381911
MyChart in Patients With Inflammatory Bowel Disease.
NCT03241992
Patient Navigation in Cancer Survivorship at a Safety Net Institution
NCT03271099
Oral Versus Intravenous Sedation for Ocular Procedures
NCT03246724
Gabby Implementation: Parent Protocol
NCT04514224
Post Hemorrhoidectomy Anorectal Pain
NCT03240185
Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials
NCT02742740
Conversational Agents to Improve Quality of Life in Palliative Care
NCT02750865
Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab
NCT03056924
Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation
NCT02836067
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 24 |
| Phase 3 | 9 |
| Phase 4 | 9 |
Therapeutic Areas
What is open in the Boston Medical Center pipeline
28 recruiting of 253 indexed (11% open); 177 completed (70%).
Phase mix: 18 late (III/IV) vs 47 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston Medical Center: open-pipeline peers nationwide
Peers matched on 253 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Boston Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 253 trials (± recruiting share)
- University of South Florida · 252 trials · 17% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
Sponsors near 11% open enrollment (± trial volume)
- The Miriam Hospital · 11% recruiting · 136 trials
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
Related
What to do with this Boston Medical Center page
253 registered trials is a research-attention snapshot, not an endorsement of Boston Medical Center or any single study.
- 28 of Boston Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Boston Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Boston Medical Center pipeline card: 253 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.